Treatment of Hepatitis C-Mediated Glomerular Disease

Publisher： Karger

E-ISSN： 1660-2110|119|2|c121-c130

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.119, Iss.2, 2011-07, pp. : c121-c130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologic Treatment in Glomerular Disease

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 203-204

Karger

Access to resources Recommend Favorite

Cost‐effectiveness of hepatitis C treatment for patients in early stages of liver disease

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1860-1869

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of Hepatitis C Virus Infection with Proteinuria and Glomerular Filtration Rate

By  

CLINICAL AND TRANSLATIONAL SCIENCE (ELECTRONIC), Vol. 8, Iss. 5, 2015-10 ,pp. : 421-424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus–mediated liver disease posttransplantation

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 28-38

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advances in the Understanding of Complement Mediated Glomerular Disease: Implications for Recurrence in the Transplant Setting

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 2, 2015-02 ,pp. : 312-319

John Wiley & Sons Inc

Access to resources Recommend Favorite